These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 416538)

  • 41. Nonhuman primate restraint device for ocular drug studies.
    Casey WJ; Hart BK; Tarleton WA
    Lab Anim Sci; 1975 Aug; 25(4):483-6. PubMed ID: 807776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmaceutical and clinical evaluation of soluble pilocarpine eye films].
    Maĭchuk IuF; Erichev VP
    Vestn Oftalmol; 1981; (2):48-50. PubMed ID: 7015673
    [No Abstract]   [Full Text] [Related]  

  • 43. Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and cats.
    Lee KC; Silver PJ; Bode DC; Gherezghiher T
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):527-34. PubMed ID: 8309316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs.
    Holland MG
    Ann Ophthalmol; 1974 May; 6(5):447-50 passim. PubMed ID: 4208894
    [No Abstract]   [Full Text] [Related]  

  • 45. A comparison of action of dexamethasone and medrysone on human intraocular pressure.
    Drance SM; Scott S
    Can J Ophthalmol; 1968 Apr; 3(2):159-61. PubMed ID: 5660429
    [No Abstract]   [Full Text] [Related]  

  • 46. Studies on the ocular pharmacology of prostaglandin D2.
    Woodward DF; Hawley SB; Williams LS; Ralston TR; Protzman CE; Spada CS; Nieves AL
    Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):138-46. PubMed ID: 2298534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Present-day views on the mechanism of action and possible clinical use of adrenergic drugs in ophthalmology].
    Goś R; Stankiewicz A
    Klin Oczna; 1974 Mar; 44(3):287-93. PubMed ID: 4207063
    [No Abstract]   [Full Text] [Related]  

  • 48. [Deendence of intraocular pressure on blood pressure, circulatory volume, and resistance to flow (clinical and experimental animal studies].
    Sayegh F
    Adv Ophthalmol; 1975; 29():185-9. PubMed ID: 805514
    [No Abstract]   [Full Text] [Related]  

  • 49. [Changes in intraocular pressure, dynamics of intraocular fluid and blood supply following the use of a 2 percent adrenalin solution in the eyes of rabbits].
    Pliushko DG
    Oftalmol Zh; 1970; 25(3):218-21. PubMed ID: 5469364
    [No Abstract]   [Full Text] [Related]  

  • 50. Indomethacin blocks arachidonic acid-induced elevation of intraocular pressure.
    Podos SM; Becker B; Kass MA
    Prostaglandins; 1973 Jan; 3(1):7-16. PubMed ID: 4632738
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of different irrigating solutions on aqueous humour pH changes, intraocular pressure and histological findings after induced alkali burns.
    Kompa S; Redbrake C; Hilgers C; Wüstemeyer H; Schrage N; Remky A
    Acta Ophthalmol Scand; 2005 Aug; 83(4):467-70. PubMed ID: 16029272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemical sympathectomy in glaucoma therapy: an investigation of alpha and beta adrenergic supersensitivity.
    Holland MG; Wei CP
    Ann Ophthalmol; 1973 Jul; 5(7):783-96. PubMed ID: 4716948
    [No Abstract]   [Full Text] [Related]  

  • 53. The ocular effects of epinephrine.
    Drance SM; Ross RA
    Surv Ophthalmol; 1970 Jan; 14(4):330-5. PubMed ID: 4906586
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hypotensive and miotic action of stabilized solutions of physostigmine and physostigmine-pilocarpine (experimental data)].
    Fauziia Saied AKh; Sporova NA; Kondrat'eva TS
    Vestn Oftalmol; 1978; (5):17-8. PubMed ID: 706040
    [No Abstract]   [Full Text] [Related]  

  • 55. [Experimental research on the behavior of ocular pressure following rupture of the hemato-ophthalmic barrier].
    Bucci MG; Santillo C
    Boll Ocul; 1970 Jan; 49(1):69-86. PubMed ID: 5493135
    [No Abstract]   [Full Text] [Related]  

  • 56. Topical corticosteroids and non-glaucomatous pseudoexfoliation.
    Tarkkanen A; Horsmanheimo A
    Acta Ophthalmol (Copenh); 1966; 44(3):323-34. PubMed ID: 5953228
    [No Abstract]   [Full Text] [Related]  

  • 57. [Problems on pharmaceutical treatment in ophthalmology].
    Kirisawa N
    Nippon Ganka Gakkai Zasshi; 1968 Oct; 72(10):1966-80. PubMed ID: 5751414
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacology and toxicology of ophthalmic drugs.
    Macri FJ
    Arch Ophthalmol; 1970 Oct; 84(4):532-45. PubMed ID: 4923815
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of pathological conditions on drug penetration into the anterior segment.
    Foulks GN
    Int Ophthalmol Clin; 1980; 20(3):51-9. PubMed ID: 6998900
    [No Abstract]   [Full Text] [Related]  

  • 60. Acute ocular tolerance of corticosteroidal solutions.
    Schlagel CA; Hagans JA; Soda JA; Lamb DJ
    J Clin Pharmacol J New Drugs; 1968; 8(4):245-53. PubMed ID: 4873483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.